batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Radiopharma doubts mount up for Cellectar 23 July 2024 Another Epkinly lymphoma combo goes pivotal 22 July 2024 Sotio builds a presence in antibody conjugates 17 July 2024 Caribou puts another nail in the Car-NK coffin 17 July 2024 The SHP2 ship sails 17 July 2024 In vivo Car-T heads for the clinic, but it’s not Sana’s 15 July 2024 Keros challenges Geron 15 July 2024 Roche declares KRAS war on Amgen and Bristol 12 July 2024 Load More